Kolexia
Boussageon Rémy
Médecine générale
Cabinet libéral
Lyon, France
320 Activités
523 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète de type 2 Diabète Angiopathies diabétiques Hypertension artérielle Défaillance cardiaque COVID-19 Infarctus du myocarde Alcoolisme Confusion

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Are American Diabetes Association's new guidelines reliable?
Journal of evaluation in clinical practice   11 décembre 2023
A critical appraisal of acute sore throat guidelines using the AGREE II instrument: a scoping review.
Family practice   15 juin 2023
Does the use of antipyretics prolong illness? A systematic review of the literature and meta-analysis on the effects of antipyretics in acute upper and lower respiratory tract infections.
Infectious diseases now   02 mai 2023
Critical appraisal of international guidelines for the management of Helicobacter pylori infection in case of dyspepsia.
Helicobacter   14 mars 2023
Does aspirin have a place in primary cardiovascular prevention by the polypill ? Simulation study on a realistic virtual population.
Therapie   04 février 2023
Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients.
Therapie   20 octobre 2022
Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis.
BMJ medicine   14 septembre 2022
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits.
Diabetologia   04 août 2022
Impact of a phone call with a medical student/general practitioner team on morbidity of chronic patients during the first French COVID-19 lockdown (COVIQuest): a cluster randomised trial.
BMJ open   28 juillet 2022
Metformin and microvascular complications: Are we sure?
Diabetes research and clinical practice   21 juillet 2022